Mapping of Apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy

Majority of CHRONIC myeloid leukemia patients experience an adequate therapeutic effect from imatinib however, 26–37% of patients discontinue imatinib therapy due to a suboptimal response or intolerance. Here we investigated derivatives of apoptin, a chicken anemia viral protein with selective toxic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jangamreddy, Jaganmohan R., Panigrahi, Soumya, Lotfi, Kourosh, Yadav, Manisha, Maddika, Subbareddy, Tripathi, Anil Kumar, Sanyal, Sabyasachi, Łos, Marek J.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196195/
https://ncbi.nlm.nih.gov/pubmed/25216532
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars